etodolac has been researched along with Adenocarcinoma, Basal Cell in 3 studies
Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, we show that the R-enantiomer of the nonsteroidal antiinflammatory drug etodolac inhibited tumor development and metastasis in the transgenic mouse adenocarcinoma of the prostate (TRAMP) model, by selective induction of apoptosis in the tumor cells." | 3.73 | The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis. ( Bernasconi, M; Carson, DA; Corr, M; Cottam, HB; James, SY; Kolluri, SK; Leoni, LM; Liu, W; Lu, D; Zhang, XK, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kolluri, SK | 1 |
| Corr, M | 1 |
| James, SY | 1 |
| Bernasconi, M | 1 |
| Lu, D | 1 |
| Liu, W | 1 |
| Cottam, HB | 1 |
| Leoni, LM | 1 |
| Carson, DA | 1 |
| Zhang, XK | 1 |
| Kaihara, T | 1 |
| Fu, KI | 1 |
| Sano, Y | 1 |
| Yamashita, K | 1 |
| Ochiai, A | 1 |
| Yoshida, S | 1 |
| Fujimori, T | 1 |
| Sugihara, I | 1 |
| Yoshida, M | 1 |
| Shigenobu, T | 1 |
| Takagi, H | 1 |
| Maruyama, K | 1 |
| Takeuchi, N | 1 |
| Toda, M | 1 |
| Inoue, M | 1 |
| Nakada, H | 1 |
3 other studies available for etodolac and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis.
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Proliferation; Eto | 2005 |
Depressed-type early invasive colon cancer in a patient treated with cyclooxygenase-2 inhibitor.
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Colonic Neoplasms; Colonic Polyps; Cyclooxy | 2006 |
Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice.
Topics: Adenocarcinoma; Animals; Cell Growth Processes; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 | 2006 |